Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Insulet Corp
(NQ:
PODD
)
171.40
+2.22 (+1.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Insulet Corp
< Previous
1
2
3
4
5
6
Next >
5 Stocks To Buy On The Dip To Gain From The Wall Street Rally
March 23, 2024
Wall Street had a dream run in 2023, reversing the nightmare of 2022. The impressive bull run appears set to continue in 2024. Thus, here is a look at some stocks that may be worth buying on the dip...
Via
Talk Markets
Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation.
March 14, 2024
INSULET CORP (NASDAQ:PODD) qualifies as a high growth stock and is consolidating.
Via
Chartmill
Is It Time to Buy the S&P 500's 3 Worst-Performing February Stocks?
March 04, 2024
A handful of large-cap stocks are now on sale. The discount, however, doesn't necessarily make them worth buying.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit)
February 29, 2024
Nvidia Corp. is one of the leading top stocks with 60% gain in 2024, but other lesser-known names have outperformed.
Via
Benzinga
Analyst Scoreboard: 5 Ratings For Insulet
February 23, 2024
Via
Benzinga
Insulet: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Should you consider NASDAQ:PODD for growth investing?
February 01, 2024
Exploring INSULET CORP (NASDAQ:PODD)'s growth characteristics.
Via
Chartmill
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
February 26, 2024
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
DexCom: A Winner In Diabetes Management
February 25, 2024
Diabetes management and glucose monitoring solutions provider DexCom, Inc. recently released its fourth-quarter results, reporting $1.0 billion in revenue, up 27% year-over-year compared to $820...
Via
Talk Markets
Nasdaq, S&P 500 Set for Mixed Open After Nvidia Euphoria: Analyst Picks Major Market Catalyst This Year If There Are No Rate Cuts
February 23, 2024
After the exuberance seen on Thursday, investors may assess whether it was an irrational one, and futures trading on Friday reflects edginess.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
INSULET CORP (NASDAQ:PODD) is a candidate for growth investors. Here's why.
January 10, 2024
Exploring growth characteristics of INSULET CORP (NASDAQ:PODD).
Via
Chartmill
Expert Ratings For Insulet
December 21, 2023
Via
Benzinga
Should you consider NASDAQ:PODD for growth investing?
December 19, 2023
Exploring growth characteristics of INSULET CORP (NASDAQ:PODD).
Via
Chartmill
What 8 Analyst Ratings Have To Say About Insulet
December 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 22, 2024
Via
Benzinga
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum
February 22, 2024
Market participants remain attentive to several factors shaping the day's trading landscape, including scheduled Fed speeches, weekly jobless claims data, and private-sector activity readings.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Top Stock Picks For Week Of December 25, 2023
December 27, 2023
MoneyLion Inc. is a data-driven, digital financial platform. Insulet Corporation is a leading developer, manufacturer, and marketer of the Omnipod Insulin Management System.
Via
Talk Markets
Should you consider NASDAQ:PODD for growth investing?
November 28, 2023
Why INSULET CORP (NASDAQ:PODD) qualifies as a high growth stock.
Via
Chartmill
Why the growth investor may take a look at NASDAQ:PODD.
November 07, 2023
INSULET CORP (NASDAQ:PODD) may be suited for growth investing, we'll explore why in this article.
Via
Chartmill
Earnings Scheduled For February 22, 2024
February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
Via
Benzinga
Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
December 21, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
Via
Benzinga
What Stocks Drove The Recent Record Rally? A Breakdown You Can't Miss
November 07, 2023
The technology sector has done well during the recent stock market rally as seen in indices such as Nasdaq 100 and S&P 500.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Barron's Weekend Stock Picks: Chevron, Apple, Disney And Insulet's Stock Increase
November 04, 2023
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
Via
Benzinga
Insulet Surges After Eye-Popping Earnings Growth Wallops Expectations
November 03, 2023
Insulet makes an insulin pump called Omnipod. U.S. sales are on the rise.
Via
Investor's Business Daily
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
November 03, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Omnipod Insulin Pump Working Well For Insulet, Lifts Annual Forecast
November 03, 2023
Insulet Corporation (NASDAQ: PODD) reported Q3 sales of $432.7 million, up 27.0%, or 25.1% in constant currency, beating the
Via
Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
October 27, 2023
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.